CompletedPhase 4ACTRN12611000631909

Vitamin D Deficiency in Human Immunodeficiency Virus

The effect of Cholecalciferol and dietary advice on Vitamin D levels in participants with Human Immunodeficiency Virus Infection

Sponsor

The Alfred Hospital Research Trust

Enrollment

40 participants

Start Date

Jul 2, 2009

Study Type

Interventional

Conditions

Human Immundeficiency Infection Vitamin D Deficiency

Summary

The primary purpose of the study is to measure the prevalence of vitamin D deficiency in the HIV population at the Alfred Hospital, and then to evaluate the effectiveness of vitamin D supplementation in this population.

Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Inclusion Criteria3

Documented HIV infection
Age greater than 18 years
Vitamin D deficiency (<50 nmol/l)

Exclusion Criteria2

Pregnancy
On vitamin D supplementation

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Supplementation with 5000 IU Cholecalciferol orally, daily for 12 months, in addition to a single 30 minute interview with dietitian at baseline with provision of dietary advice regarding sources of v

Locations(1)

The Alfred - Prahran

VIC, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000631909

Related Trials

The Effect of Vitamin D Supplementation on the Anti-inflammatory Response in Periodontal Diseases

NCT076367331 location

Bone Myoregulation Reflex and Postural Control in Vitamin D Deficiency

NCT074359351 location

Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients

NCT046778161 location

A Household-Based Dietary Intervention Study of Vitamin D Fortified Bread in Irish Families

NCT074812402 locations

Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)

NCT043555721 location